“Some of the main symptoms to be aware of are needing to pee more frequently (often during the night); needing to rush to the ...

A live webcast of the event, as well as an archived recording, will be available on the “Investors” section of the Company’s website at https://ir.procept-biorobotics.com/. The webcast will be ...

Updated clinical & translational results: BOND-003 Cohort C- A phase 3, single-arm study of intravesical cretostimogene grenadenorepvec for high-risk BCG-unresponsive non-muscle invasive bladder ...

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...

Sexual function data support enzalutamide use in men with high-risk biochemically recurrent (BCR) prostate cancer.

Findings in patients with interstitial cystitis/bladder pain syndrome can help with diagnosis of interstitial cystitis subtypes ...

The management and treatment of prostate cancer is evolving to address unmet patient needs, with advancements spanning from diagnosis ...

U.S. Urology Partners is one of the first providers to offer patients ImmunityBio’s recombinant Bacillus Calmette-Guérin (rBCG) The FDA recently authorized ImmunityBio’s EAP for rBCG to address U.S.

The Department of Urology residency program is a five year program consisting of a preliminary year followed by four years of urology. Our preliminary year provides an introduction to urology and ...

Urology of Virginia, a globally recognized leader in urologic care, is reinventing patient education and clinic efficiency ...